Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 19 June 2012
[DOI: 10.1126/scisignal.2003111]

Supplementary Materials for:

Direct Modification and Activation of a Nuclear Receptor–PIP2 Complex by the Inositol Lipid Kinase IPMK

Raymond D. Blind, Miyuki Suzawa, Holly A. Ingraham*

*To whom correspondence should be addressed. E-mail: holly.ingraham{at}ucsf.edu

This PDF file includes:

  • Fig. S1. p110γ, the kinase-dead rIPMK mutant (D127A), and IP3K fail to generate PIP3 from SF-1–PIP2.
  • Fig. S2. Enzyme/substrate kinetic parameters and competitive inhibition by Ins(1,4,5)P of IPMK activity on SF-1–PIP2.
  • Fig. S3. Overexpression of different IPMKs does not affect SF-1 transcript abundance.
  • Fig. S4. SF-1 transcript abundance and SF-1 nuclear localization are unaffected by ATA and EGCG, and wortmannin does not recapitulate ATA effects on SF-1 target gene expression.
  • Fig. S5. SF-1 purified from HEK 293 cells is not phosphorylated by IPMK.
  • Table S1. RT-qPCR primers.
  • Table S2. ChIP-qPCR primers.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 743 KB

Citation: R. D. Blind, M. Suzawa, H. A. Ingraham, Direct Modification and Activation of a Nuclear Receptor–PIP2 Complex by the Inositol Lipid Kinase IPMK. Sci. Signal. 5, ra44 (2012).

© 2012 American Association for the Advancement of Science

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882